Tower Research Capital (TRC)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$245K	Buy	6,755 +632	+10%	+$28.2K	0.01%	1452
2025 Q4	$285K	Buy	6,123 +3,263	+114%	+$145K	0.01%	1184
2025 Q3	$119K	Sell	2,860 -9,908	-78%	-$317K	﹤0.01%	1861
2025 Q2	$367K	Buy	12,768 +12,235	+2,295%	+$378K	0.01%	1238
2025 Q1	$17.9K	Sell	533 -6,879	-93%	-$257K	﹤0.01%	3084
2024 Q4	$379K	Buy	7,412 +6,960	+1,540%	+$389K	0.01%	1251
2024 Q3	$23.1K	Sell	452 -12,404	-96%	-$640K	﹤0.01%	3163
2024 Q2	$576K	Buy	12,856 +12,281	+2,136%	+$567K	0.01%	1223
2024 Q1	$26.9K	Sell	575 -3,028	-84%	-$118K	﹤0.01%	2740
2023 Q4	$128K	Buy	3,603 +2,039	+130%	+$62.5K	﹤0.01%	2442
2023 Q3	$46.5K	Sell	1,564 -2,980	-66%	-$61.4K	﹤0.01%	2608
2023 Q2	$81.9K	Buy	4,544 +2,617	+136%	+$52.2K	﹤0.01%	2190
2023 Q1	$31K	Buy	1,927 +1,009	+110%	+$18.7K	﹤0.01%	2948
2022 Q4	$17K	Sell	918 -9,271	-91%	-$163K	﹤0.01%	3264
2022 Q3	$200K	Buy	10,189 +5,687	+126%	+$116K	﹤0.01%	1928
2022 Q2	$84K	Sell	4,502 -12,242	-73%	-$244K	﹤0.01%	2420
2022 Q1	$368K	Buy	16,744 +13,226	+376%	+$268K	﹤0.01%	1337
2021 Q4	$100K	Sell	3,518 -247	-7%	-$6.09K	﹤0.01%	2220
2021 Q3	$79K	Buy	3,765 +1,881	+100%	+$39.3K	﹤0.01%	2595
2021 Q2	$36K	Buy	1,884 +1,233	+189%	+$21.7K	﹤0.01%	3296
2021 Q1	$10K	Sell	651 -5,422	-89%	-$84K	﹤0.01%	4359
2020 Q4	$86K	Sell	6,073 -16,811	-73%	-$234K	﹤0.01%	2495
2020 Q3	$359K	Buy	22,884 +19,582	+593%	+$299K	﹤0.01%	2017
2020 Q2	$58K	Buy	+3,302	New	+$56.3K	﹤0.01%	2930
2019 Q4	–	Sell	-2,691	Closed	-$40K	–	3661
2019 Q3	$40K	Buy	2,691 +2,194	+441%	+$42.7K	﹤0.01%	1955
2019 Q2	$12K	Sell	497 -572	-54%	-$14.2K	﹤0.01%	2448
2019 Q1	$24K	Sell	1,069 -739	-41%	-$18.2K	﹤0.01%	2161
2018 Q4	$54K	Buy	+1,808	New	+$50.9K	﹤0.01%	1242